We recently reported that
doxorubicin decreased the expression of
calpain-1/2, while inhibition of
calpain activity promoted
doxorubicin-induced cardiac injury in mice. In this study, we investigated whether and how elevation of calpain-2 could affect
doxorubicin-triggered cardiac injury. Transgenic mice with inducible cardiomyocyte-specific expression of calpain-2 were generated. An acute
cardiotoxicity was induced in both transgenic mice and their relevant wild-type littermates by injection of a single dose of
doxorubicin (20 mg/kg) and cardiac injury was analyzed 5 days after
doxorubicin injection. Cardiomyocyte-specific up-regulation of calpain-2 did not induce any adverse cardiac phenotypes under physiological conditions by age 3 months, but significantly reduced myocardial injury and improved myocardial function in
doxorubicin-treated mice. Cardiac protection of calpain-2 up-regulation was also observed in a mouse model of chronic
doxorubicin cardiotoxicity. Up-regulation of calpain-2 increased the
protein levels of
mitogen activated protein kinase phosphatase-1 (MKP-1) in cultured mouse cardiomyocytes and heart tissues. Over-expression of MKP-1 prevented, whereas knockdown of MKP-1 augmented
doxorubicin-induced apoptosis in cultured cardiomyocytes. Moreover, knockdown of MKP-1 offset calpain-2-elicited protective effects against
doxorubicin-induced injury in cultured cardiomyocytes. Mechanistically, up-regulation of calpain-2 reduced the
protein levels of
phosphatase and
tensin homolog and consequently promoted Akt activation, leading to increased MKP-1
protein steady-state levels by inhibiting its degradation. Collectively, this study reveals a new role of calpain-2 in promoting MKP-1 expression via
phosphatase and
tensin homolog/Akt signaling. This study also suggests that
calpain-2/MKP-1 signaling may represent new therapeutic targets for
doxorubicin-induced cardiac injury.